117 related articles for article (PubMed ID: 2440407)
1. [The role of plasma alpha 1-glycoprotein acid in the binding of aminopyrine].
el Allaf D; Demey-Ponsart E; Pirotte J; Chapelle JP; el Allaf M; Carlier J; Van Cauwenberge H
Arch Int Physiol Biochim; 1986 Dec; 94(5):317-22. PubMed ID: 2440407
[TBL] [Abstract][Full Text] [Related]
2. [Serum protein binding of fentanyl. The effect of postoperative acute phase reaction with elevated alpha 1-acid glycoprotein and methodologic problems in determination by equilibrium dialysis].
Wiesner G; Taeger K; Peter K
Anaesthesist; 1996 Apr; 45(4):323-9. PubMed ID: 8702049
[TBL] [Abstract][Full Text] [Related]
3. Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction.
Routledge PA; Stargel WW; Wagner GS; Shand DG
Ann Intern Med; 1980 Nov; 93(5):701-4. PubMed ID: 7212479
[TBL] [Abstract][Full Text] [Related]
4. The contribution of alpha 1-acid glycoprotein, lipoproteins, and albumin to the plasma binding of perazine, amitriptyline, and nortriptyline in healthy man.
Brinkschulte M; Breyer-Pfaff U
Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):61-6. PubMed ID: 6108517
[TBL] [Abstract][Full Text] [Related]
5. Melatonin high-affinity binding to alpha-1-acid glycoprotein in human serum.
Morin D; Simon N; Deprés-Brummer P; Lévi F; Tillement JP; Urien S
Pharmacology; 1997 May; 54(5):271-5. PubMed ID: 9380773
[TBL] [Abstract][Full Text] [Related]
6. Prazosin binding to human alpha 1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the 'single drug binding site' of orosomucoid.
Brunner F; Müller WE
J Pharm Pharmacol; 1985 May; 37(5):305-9. PubMed ID: 2862237
[TBL] [Abstract][Full Text] [Related]
7. SKF 525A displaces drugs from serum alpha 1-acid glycoprotein binding sites.
Belpaire FM; Chindavijak B; Bogaert MG
J Pharmacol Exp Ther; 1987 Feb; 240(2):628-30. PubMed ID: 3806415
[TBL] [Abstract][Full Text] [Related]
8. The binding of chemically different psychotropic drugs to alpha 1-acid glycoprotein.
Schley J; Müller-Oerlinghausen B
Pharmacopsychiatria; 1983 May; 16(3):82-5. PubMed ID: 6611652
[TBL] [Abstract][Full Text] [Related]
9. alpha 1-acid glycoprotein involvement in high affinity binding of tricyclic antidepressants to human plasma.
Javaid JI; Hendricks K; Davis JM
Biochem Pharmacol; 1983 Apr; 32(7):1149-53. PubMed ID: 6847707
[TBL] [Abstract][Full Text] [Related]
10. Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction.
Routledge PA; Shand DG; Barchowsky A; Wagner G; Stargel WW
Clin Pharmacol Ther; 1981 Aug; 30(2):154-7. PubMed ID: 7249498
[TBL] [Abstract][Full Text] [Related]
11. Binding of disopyramide to alpha 1-acid glycoprotein in plasma measured by competitive equilibrium dialysis.
Norris RL; Ahokas JT; Ravenscroft PJ; Henry M
J Pharm Sci; 1984 Jun; 73(6):824-6. PubMed ID: 6737271
[TBL] [Abstract][Full Text] [Related]
12. Serum alpha-1-acid glycoprotein (orosomucoid) in uremic patients on hemodialysis.
Henriksen HJ; Petersen MU; Pedersen FB
Nephron; 1982; 31(1):24-6. PubMed ID: 7110472
[TBL] [Abstract][Full Text] [Related]
13. Influence of continuous ambulatory peritoneal dialysis on serum alpha 1-acid glycoprotein concentration and drug binding.
Belpaire FM; Van de Velde EJ; Fraeyman NH; Bogaert MG; Lameire N
Eur J Clin Pharmacol; 1988; 35(4):339-43. PubMed ID: 3197741
[TBL] [Abstract][Full Text] [Related]
14. Binding of several phenothiazine neuroleptics to a common binding site of alpha 1-acid glycoprotein, orosomucoid.
El-Gamal S; Wollert U; Müller WE
J Pharm Sci; 1983 Feb; 72(2):202-5. PubMed ID: 6131996
[TBL] [Abstract][Full Text] [Related]
15. The binding of selected therapeutic drugs to human serum alpha-1 acid glycoprotein and to human serum albumin in vitro.
Bailey DN; Briggs JR
Ther Drug Monit; 2004 Feb; 26(1):40-3. PubMed ID: 14749548
[TBL] [Abstract][Full Text] [Related]
16. Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipients.
Haughey DB; Kraft CJ; Matzke GR; Keane WF; Halstenson CE
Am J Nephrol; 1985; 5(1):35-9. PubMed ID: 3881959
[TBL] [Abstract][Full Text] [Related]
17. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
Holladay JW; Dewey MJ; Michniak BB; Wiltshire H; Halberg DL; Weigl P; Liang Z; Halifax K; Lindup WE; Back DJ
Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499
[TBL] [Abstract][Full Text] [Related]
18. Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.
David BM; Ilett KF; Whitford EG; Stenhouse NS
Br J Clin Pharmacol; 1983 Apr; 15(4):435-41. PubMed ID: 6849779
[TBL] [Abstract][Full Text] [Related]
19. Dynamic variability of binding of antiarrhythmic drugs during the evolution of acute myocardial infarction.
Kessler KM; Kissane B; Cassidy J; Pefkaros KC; Kozlovskis P; Hamburg C; Myerburg RJ
Circulation; 1984 Sep; 70(3):472-8. PubMed ID: 6744551
[TBL] [Abstract][Full Text] [Related]
20. Altered therapeutic range for quinidine after myocardial infarction and cardiac surgery.
Garfinkel D; Mamelok RD; Blaschke TF
Ann Intern Med; 1987 Jul; 107(1):48-50. PubMed ID: 3109296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
